With more than 200 exhibitors attending and more than 1,100 technical talks scheduled, SPIE Defense + Commercial Sensing is set for a triumphant return to Orlando this year. The program is now live and registration is open for the event, which runs from April 3-7 at the Gaylord Palms Resort & Convention Center in Orlando, Florida.
Program highlights include a Florida photonics industry showcase, with speakers from eight Florida Photonics Cluster companies whose technologies are providing cutting-edge solutions for both the commercial sector and the defense and security industries: LightPath, Pangolin Laser Systems, L3Harris, Ocean Insight, OptiGrate, Beam Engineering, Optronic Labs, and Jenoptik. There's also a public-policy update with SPIE Government Affairs Director Jennifer O'Bryan; a thermo-imaging-focused vendor showcase and reception; a two-day-long Job Fair on April 5-6; and multiple opportunities for networking, connecting, and discussions with technology suppliers.
The five-day program also features a slate of plenary speakers who will address key topics that range from the latest focus on materials and devices and imaging and analytics, to ATR and next-generation sensors.
Twenty course offerings include "Fundamentals of Infrared Sensing," "Introduction to Optomechanical Design," and "Interpreting Deep Learning Networks," while technical sessions will cover the latest in quantum, imaging, sensing, and other applications key to the defense and commercial industries.
"We are very happy to be returning to Orlando for this year's SPIE Defense + Commercial Sensing," said SPIE CEO Kent Rochford. "There's nothing like in-person events — especially in a place like Orlando, a region with an active and innovative industry and research community — and we are very much looking forward to connecting with all of our attendees and exhibitors in April."
SPIE Defense + Commercial Sensing will be adhering to the CDC Guidance for Activities and Gatherings and will require proof of a negative covid test prior to attending. Proof of an approved COVID vaccine can be used in lieu of a negative test.
For more information, visit https://spie.org/conferences-and-exhibitions/defense-and-commercial-sensing.